Health and well-being of maturing adults with classic galactosemia
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Long-term classic galactosemia (CG) complications appear stable in adulthood, not worsening with age. This study of adults with CG suggests most patients do not experience progressive health issues.
Area Of Science
- Metabolic disorders
- Genetics
- Longitudinal studies
Background
- Classic galactosemia (CG) is a rare genetic disorder.
- Previous studies on CG long-term outcomes were limited by small sample sizes or narrow age ranges.
- Understanding adult outcomes in CG is crucial for patient management.
Purpose Of The Study
- To investigate long-term health and well-being in adults with classic galactosemia.
- To determine if adverse outcomes associated with CG progress with age.
- To identify potential modifiers of CG outcomes.
Main Methods
- Anonymous surveys administered to 92 adults with CG (ages 30-78) and 38 sibling controls (ages 30-79).
- Participants reported on outcomes in speech/voice/language, cognition, motor function, cataracts, bone health, psychosocial well-being, gastrointestinal health, and ovarian function.
- Statistical analysis explored associations between outcomes and candidate modifiers (neonatal milk exposure, dietary rigor, age, continent).
Main Results
- Long-term complications in adults with CG were consistent with those reported in younger cohorts.
- No significant progression of adverse outcomes was observed with increasing age for most patients.
- Cataracts showed association with neonatal milk exposure and age; bone health with home continent.
Conclusions
- Adverse outcomes in classic galactosemia appear to stabilize in adulthood for the majority of patients.
- The findings suggest that current management strategies may prevent disease progression in adult life.
- Further research into specific outcome modifiers is warranted.
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
Related Concept Videos
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Class I comprises GLUT1 to GLUT4 and GLUT14.
Class II has GLUT5, GLUT7,...
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
Carbohydrate metabolism is a fundamental biochemical process that ensures a constant supply of energy to living cells. The most important carbohydrate is glucose, which can be broken down via glycolysis to enter into the Krebs cycle and eventually lead to the production of ATP through oxidative phosphorylation.
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...